BURTON SOBEL, M.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Oruka Therapeutics, Inc.

Filing Date Source Excerpt
2013-02-01 Burton Sobel, M.D. is listed as a director with beneficial ownership of 20,875 shares. No specific age, committees, or compensation details are provided.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22